| 1. |
Walston J, Silver K, Hilfiker H, et al. Insulin response to glucose is lower in individuals homozygous for the Arg 64 variant of the beta-3-adrenergic receptor[J]. J Clin Endocrinol Metab, 2000, 85(11):4019-4022.
|
| 2. |
Masuo K, Katsuya T, Fu Y, et al. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals[J]. Am J Hypertens, 2005, 18(7):1009-1014.
|
| 3. |
Little J, Higgins JP, Ioannidis JP, et al. Strengthening the reporting of genetic association studies (STREGA):an extension of the STROBE statement[J]. Eur J Epidemiol, 2009, 24(1):37-55.
|
| 4. |
王靜, 莫傳偉, 陳群, 等.應用Stata軟件的Meta分析完成醫學科研定量評價[J].中華中醫藥學刊, 2008, 26(5):947-949.
|
| 5. |
包愛民, 肖尚喜, 王長江, 等. 2型糖尿病與正常人群中β3腎上腺素能受體基因Trp64Arg多態性表型特征[J].中國糖尿病雜志, 2000, 8(1):13-16.
|
| 6. |
孫黎明, Iizuka Y, Ishibashi S, 等.中國人與日本人β3腎上腺素能受體基因Trp64Arg突變的比較[J].中華醫學雜志, 2000, 80(2):107-110.
|
| 7. |
陳玉, 周玲, 徐耀初, 等.β3-腎上腺素能受體基因與2型糖尿病關系的研究[J].中國公共衛生, 2001, 17(7):586-588.
|
| 8. |
李耀明, 梁劍寧. 2型糖尿病與β3腎上腺素能受體基因Trp64Arg多態性的相關性探討[J].廣州醫學院學報, 2004, 32(2):60-62.
|
| 9. |
孫玉茹, 楊澤, 紀立農.β3腎上腺素能受體基因Trp64Arg變異與2型糖尿病的關聯研究[J].中華糖尿病雜志, 2004, 12(1):43-44.
|
| 10. |
修玲玲, 翁建平, 隋昳, 等.解偶聯蛋白2基因和β3-腎上腺素能受體基因聯合變異與2型糖尿病及肥胖癥的關系[J].中華醫學雜志, 2004, 84(5):375-379.
|
| 11. |
惠宗光, 周學偉, 王曉玲, 等. 2型糖尿病人群胰島素抵抗和β3-AR基因的相關性[J].濰坊醫學院學報, 2005, 27(3):173-175.
|
| 12. |
李利, 孫黎明, 王軍, 等.β3腎上腺素能受體基因Trp64Arg突變與胰島素抵抗相關[J].中國醫師雜志, 2006, 8(5):636-638.
|
| 13. |
姜秀云, 侯新國, 侯為開, 等.腎上腺素能β3受體基因多態性與肥胖和胰島素抵抗的相關性[J].中國糖尿病雜志, 2007, 15(9):526-527.
|
| 14. |
李慧華, 楊敏, 余敏, 等. β3-AR Trp64Arg遺傳多態性對T2DM患者羅格列酮療效的影響[J].中國藥理學通報, 2009, 25(3):317-321.
|
| 15. |
孟曉嶸, 駱杰偉, 鄭姜欽, 等. 2型糖尿病痰濕證的β3腎上腺素能受體基因Trp64Arg多態性分析[J].福建中醫藥, 2011, 42(5):7-8, 13.
|
| 16. |
Zaagsma J, Nahorski SR. Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical "beta 3-adrenoceptor"?[J]. Trends Pharmacol Sci, 1990, 11(1):3-7.
|
| 17. |
Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene[J]. N Engl J Med, 1995, 333(6):343-347.
|
| 18. |
Sakane N, Yoshida T, Umekawa T, et al. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients[J]. Diabetes Care, 1997, 20(12):1887-1890.
|
| 19. |
王瑤, 蕭建中, 李光偉.原發性高血壓人群胰島素抵抗與β3-腎上腺素能受體基因多態性的關聯[J].中華內分泌代謝雜志, 2001, 17(3):148-150.
|
| 20. |
Umekawa T, Yoshida T, Sakane N, et al. Anti-obesity and anti-diabetic effects of CL316, 243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats:induction of uncoupling protein and activation of glucose transporter 4 in white fat[J]. Eur J Endocrinol, 1997, 136(4):429-437.
|
| 21. |
單志桂, 楊新玲, 姚亞妮.如何運用系統評價結果進行臨床實踐[J].中國循證醫學雜志, 2012, 12(3):357-359.
|